CN1174971C - 吗啉醚 - Google Patents

吗啉醚 Download PDF

Info

Publication number
CN1174971C
CN1174971C CNB998085146A CN99808514A CN1174971C CN 1174971 C CN1174971 C CN 1174971C CN B998085146 A CNB998085146 A CN B998085146A CN 99808514 A CN99808514 A CN 99808514A CN 1174971 C CN1174971 C CN 1174971C
Authority
CN
China
Prior art keywords
methyl
group
milliliters
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998085146A
Other languages
English (en)
Chinese (zh)
Other versions
CN1309651A (zh
Inventor
J・M・比诺
J·M·比诺
槁薰痹洛
J·赤查罗贡扎洛
科特容
J·M·科特容
赛瓦斯
J·C·赛瓦斯
费安多尔
J·M·费安多尔
A·马洛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Wellcome SA
Original Assignee
Glaxo Wellcome SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome SA filed Critical Glaxo Wellcome SA
Publication of CN1309651A publication Critical patent/CN1309651A/zh
Application granted granted Critical
Publication of CN1174971C publication Critical patent/CN1174971C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
CNB998085146A 1998-05-11 1999-05-07 吗啉醚 Expired - Fee Related CN1174971C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98500117.1 1998-05-11
EP98500117 1998-05-11
EP98500204.7 1998-09-18
EP98500204 1998-09-18

Publications (2)

Publication Number Publication Date
CN1309651A CN1309651A (zh) 2001-08-22
CN1174971C true CN1174971C (zh) 2004-11-10

Family

ID=26151831

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998085146A Expired - Fee Related CN1174971C (zh) 1998-05-11 1999-05-07 吗啉醚

Country Status (13)

Country Link
EP (1) EP1077959A1 (tr)
JP (1) JP2002514632A (tr)
KR (1) KR100625146B1 (tr)
CN (1) CN1174971C (tr)
AR (1) AR016261A1 (tr)
AU (1) AU763088B2 (tr)
BR (1) BR9910377A (tr)
CA (1) CA2331584A1 (tr)
MA (1) MA26628A1 (tr)
PE (1) PE20000479A1 (tr)
TR (1) TR200003301T2 (tr)
TW (1) TW585858B (tr)
WO (1) WO1999058512A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286208A1 (en) * 2000-09-13 2002-03-26 Sankyo Company Limited Zofimarin derivatives having oxazepam ring
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
EP3252043B1 (en) * 2015-01-30 2020-09-30 NOF Corporation Cationic lipid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
EP0711784A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
EP0712859A1 (en) * 1994-11-08 1996-05-22 Glaxo, S.A. Antifungal Sordarin derivatives
PE49696A1 (es) * 1994-11-08 1996-12-05 Glaxo Wellcome Sa Compuesto carbociclico
EP0711783A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
WO1997042195A1 (en) * 1996-05-08 1997-11-13 Glaxo Wellcome S.A. Process for the preparation of an indacene compound
EP0938307B1 (en) * 1996-09-18 2003-05-07 Merck & Co., Inc. Sordarin and derivatives thereof for use as crop antifungal agents
ES2215220T3 (es) * 1996-10-07 2004-10-01 MERCK & CO., INC. Derivados de sordarina.
NZ502763A (en) * 1997-08-22 2002-03-28 Merck & Co Inc 4-cyano-4-deformylsordarin derivatives
WO1999009975A1 (en) * 1997-08-22 1999-03-04 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives

Also Published As

Publication number Publication date
AR016261A1 (es) 2001-06-20
AU4258899A (en) 1999-11-29
WO1999058512A1 (en) 1999-11-18
KR20010025009A (ko) 2001-03-26
TW585858B (en) 2004-05-01
CN1309651A (zh) 2001-08-22
JP2002514632A (ja) 2002-05-21
AU763088B2 (en) 2003-07-10
EP1077959A1 (en) 2001-02-28
CA2331584A1 (en) 1999-11-18
PE20000479A1 (es) 2000-05-29
MA26628A1 (fr) 2004-12-20
KR100625146B1 (ko) 2006-09-20
BR9910377A (pt) 2001-01-16
TR200003301T2 (tr) 2001-02-21

Similar Documents

Publication Publication Date Title
CN1231468C (zh) 化合物
CN1086386C (zh) 多药抗性修饰剂
CN1054380C (zh) 稠环化合物及其用途
CN1049431C (zh) 吗啉衍生物及其用途和含该衍生物的药物制剂
CN1165518C (zh) 作为药学试剂的双环氨基酸类化合物
CN1809568A (zh) 作为dpp－iv抑制剂的吡啶并2,1－a－异喹啉衍生物
CN101031561A (zh) 可以用作凝血因子xa抑制剂的羰基化合物
CN1678317A (zh) 用作治疗呕吐、抑郁症、焦虑症和咳嗽的神经激肽－1(nk－1)拮抗剂的1－酰氨基－4－苯基－4－苄氧基甲基－哌啶衍生物和相关化合物
CN101039916A (zh) 作为大电导钙激活k通道开启剂的咪唑衍生物
CN1155599C (zh) 三环三唑并苯并氮杂�衍生物、用于制备该衍生物的方法和抗变态反应剂
CN1093082A (zh) N，n-双取代芳基环烷基胺及其盐，含有该化合物的药物组合物及其应用以及其制备方法
CN1106390A (zh) 吡咯化合物，其生产及应用
CN86104787A (zh) 制备聚-4-氨基吡咯-2-甲酰胺基衍生物的方法
CN1037511C (zh) 1－(芳烷基－氨烷基)咪唑化合物的制备方法
CN1016871B (zh) 二环和三环吡啶衍生物的制备方法
CN1174971C (zh) 吗啉醚
CN88101674A (zh) 色酮衍生物
CN1681832A (zh) 具有抗菌活性的林可霉素衍生物
CN1069976A (zh) 环己烷和四氢吡喃衍生物
CN1040105C (zh) 制备氨基酮衍生物的方法
CN1199960C (zh) 新的沉香呋喃衍生物,它们的制备方法,含它们的药物组合物及它们作为药物的用途
CN1273463C (zh) (1－苯甲酰甲基－3－苯基－3－哌啶基乙基)哌啶衍生物,制备它们的方法以及包含它们的药物组合物
CN1098259C (zh) 新的羧基取代的环状羧酰胺衍生物
CN100345834C (zh) 异羟肟酸衍生物
CN1177842C (zh) 新的沉香呋喃衍生物、它们的药物组合物及它们制备药物的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1071346

Country of ref document: HK

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee